Research map: CYP2C19 c. 681G >A Is not in Complete Linkage Disequilibrium With c.332‐ 23A >G: Implications for Pharmacogenetic Testing
Back to the article
Papers in this map
Twelve years of SAMtools and BCFtools
· Petr Danecek · 2021 · 17144 citations · Cited by this paper
Human Pharmacokinetic Prediction of Antibody‐Drug Conjugates Using Human FcRn Transgenic Mice
· 2026 · Related
The Ensembl Variant Effect Predictor
· William M. McLaren · 2016 · 9004 citations · Cited by this paper
From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases
· 2026 · Related
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
· S.M. de Morais · 1994 · 956 citations · Cited by this paper
Deep‐Learning: An Emerging Tool to Support Model‐Informed Drug Development
· 2026 · Related
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
· J K Hicks · 2016 · 703 citations · Cited by this paper
A Generative AI Framework for Pharmacokinetic Clinical Study Report Authoring
· 2026 · Related
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
· Craig R. Lee · 2022 · 514 citations · Cited by this paper
Model‐Informed Development of a Subcutaneous Formulation of Tislelizumab: Phase 1 Pharmacokinetics in Patients With Cancer
· 2026 · Related
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 , CYP2C19 , CYP2B6 , SLC6A4 , and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
· Chad Bousman · 2023 · 454 citations · Cited by this paper
Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA / EMA
· 2026 · Related
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy
· Brad Moriyama · 2016 · 406 citations · Cited by this paper
Evaluation of a Novel Peptide‐Based ELISA for the Serological Diagnosis of Trypanosoma cruzi Infection
· 2026 · Related
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
· Katherine N. Theken · 2020 · 354 citations · Cited by this paper
Drug Interactions of Vebreltinib, a Novel Type I c‐Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants
· 2026 · Related
Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation
· Andrea Gaedigk · 2021 · 167 citations · Cited by this paper
Anti‐ PEG Antibodies From mRNA COVID ‐19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels
· 2026 · Related
PharmVar GeneFocus: CYP2C19
· Mariana Rodrigues Botton · 2020 · 148 citations · Cited by this paper
Severe Thiopurine‐Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report
· 2026 · Related
Advancing Pharmacogenomics from Single-Gene to Preemptive Testing
· Cyrine E. Haidar · 2022 · 63 citations · Cited by this paper
The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
· Amarjit S. Chaudhry · 2015 · 29 citations · Cited by this paper
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)
· Cinzia Dello Russo · 2025 · 18 citations · Cited by this paper
Notable drug-drug interaction between omeprazole and voriconazole in CYP2C19 *1 and *2 (rs4244285, 681G>A) alleles in vitro
· Xue Li · 2024 · 3 citations · Cited by this paper
Pharmacogenomic Testing: Strategies and Technical Considerations for Clinical Laboratories
· Yuan Ji · 2025 · 1 citation · Cited by this paper
Untitled · Cited by this paper
Source: OpenAlex (CC0)